about
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.Overcoming EGFR-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
P50
description
researcher
@en
name
Andreas H Scheel
@en
type
label
Andreas H Scheel
@en
prefLabel
Andreas H Scheel
@en
P31
P496
0000-0003-0244-1646